Clinical Trial Update: Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating ilaprazole for ulcer healing and prevention of gastrointestinal bleeding after endoscopic submucosal dissection in gastric cancer pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Gastric Cancer | Phase 4 | Status: COMPLETED